期刊文献+

微量清蛋白尿对重症脓毒症患者预后的预测意义 被引量:4

Predictive Value of Microalbuminuria for the Prognosis of Severe Sepsis in Intensive Care Unit
下载PDF
导出
摘要 目的探讨微量清蛋白尿(MAU)对重症脓毒症患者预后的预测价值。方法选取我院ICU31例重症脓毒症患者,测定入科1、24、48h的尿微量清蛋白(MA)与尿肌酐之比(ACR),分别记录为ACR0、ACR1和ACR2,记录患者入ICU后第一个48h尿MA的动态变化趋势(△ACR)。分析ACR、△ACR与急性生理和慢性健康状况评分系统(APACHEⅡ)评分、感染相关器官功能衰竭(SOFA)评分的相关性;比较ACR、△ACR与APACHEⅡ评分、SOFA评分对重症脓毒症患者ICU内死亡的预测分辨度。结果 31例患者存活23例,死亡8例。死亡组ACR2、△ACR、APACHEⅡ评分、SOFA评分较存活组均明显升高,差异有统计学意义(P<0.05)。△ACR增高组ACR2、A-PACHEⅡ评分、SOFA评分、机械通气时间及病死率均高于△ACR下降组,差异有统计学意义(P<0.05)。患者入ICU后ACR1、ACR2与APACHEⅡ评分呈正相关(P<0.05);ACR1、ACR2与SOFA评分呈正相关(P<0.05)。△ACR增高预测患者ICU内死亡的敏感度和特异度分别为75.0%和87.0%,阳性预测值和阴性预测值分别为66.7%和90.9%。ACR0、ACR1、ACR2、△ACR及APACHEⅡ评分、SOFA评分对ICU内死亡预测ROC曲线下面积分别为0.556、0.689、0.856、0.800、0.856、0.833。结论△ACR与重症脓毒症患者的预后相关,△ACR具有与APACHEⅡ评分、SOFA评分相似的死亡预测分辨度,可作为判断脓毒症患者在ICU内预后的一个早期预测指标。 Objective To explore the predictive value of microalbuminuria(MAU)for the prognosis of severe sepsis in intensive care unit(ICU).Methods In this prospective observational study,31 patients with sever sepsis who had been admitted to ICU of Yanan Hospital of Kunming from June 2009 to February 2010 were enrolled in this study.MAU was expressed as the urinary microalbumin/urinary creatinine ratio(ACR,the normal upper threshold is 2.7mg/mmol).Urinary samples were collected 1,24,and 48 hours after hospital admission,which were recorded as ACR0,ACR1,and ACR2,respectively.The change of the ACR during the first 48 hours was recorded as △ACR.The relationship between △ACR with the APACHEⅡ scores and the SOFA score was analyzed and the predictive values were compared.Results Of 31 patients with severe sepsis,23 survived and 8 died.△ACR,APACHEⅡ scores,and SOFA scores were significantly different between the survivors group and the death group(P〈0.05).ACR2,APACHE II scores,SOFA scores,duration of mechanical ventilation,and case-fatality rate were significantly higher among patients with increased △ACR during the first 48 hours than than with decreased △ACR(P〈0.01).ACR0 was positively correlated with ACR1 and ACR2 after the patients were admitted to ICU(both P〈0.05).Also,ACR1 and ACR2 were positively correlated with APACHEⅡ scores(both P〈0.05).The sensitivity and specificity of △ACR in predicting ICU deaths were 75.0% and 87.0%,and the positive and negative predictive values were 66.7 % and 90.9 %.The areas under ROC curves of△ACR,APACHEⅡ score and SOFA score to predictive the death in ICU were 0.800(P〈0.05),0.856(P〈0.05),and 0.833(P〈0.05),respectively.Conclusion △ACR is relevant with the prognosis of severe sepsis.△ACR has similar power as APACHEⅡ score and SOFA score in predicting the outcomes of patients with severe sepsis.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第32期3596-3600,共5页 Chinese General Practice
关键词 脓毒症 白蛋白尿 预测 Sepsis Microalbuminuria Predictor
  • 相关文献

参考文献15

  • 1American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference.Definitions for sepsis and multiple organ failure and guidelines for the use of innovative the rapies in sepsis[J].Crit Care Med,1992,20(6):864-874.
  • 2Gosling P.Microalbuminuria and cardiovascular risk:a word of caution[J].J Hum Hypertens,1998,12(4):211-213.
  • 3Knaus WA,Draper EA,Wagner DP,et al.APACHEⅡ:a severity of disease classification system[J].Crit Care Med,1985,13(10):818-829.
  • 4Vincent JL,Moreno R,Takala J,et al.The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure.On behalf of the working group on sepsis-related problems of the european society of intensive care medicine[J].Intensive Care Med,1996,22(7):707-710.
  • 5De Gaudio AR,Spina R,Di Filippo A,et al.Glomerular permeability and trauma:a correlation between microalbuminuria and injury severity score[J].Crit Care Med,1999,27(13):2105-2108.
  • 6De Gaudio AR,Adembri C,Grechi S,et al.Microalbuminuria as an early index of impairment of glomerular permeability in postoperative septic patients[J].Intensive Care Med,2000,26(9):1364-1368.
  • 7Mac Kinnon KL,Molnar Z,Lowe D,et al.Use of microalbuminuria as a predictor of outcome in critically ill patients[J].Br J Anaesth,2000,84(2):239-241.
  • 8刘晓伟,刘志.严重脓毒症并发急性肾衰竭患者92例临床研究[J].中国全科医学,2010,13(7):738-740. 被引量:11
  • 9Gosling P.Critical illness:a view from the kidney[J].Crit Care Med,2006,34(6):1852-1853.
  • 10Gosling P,Manji M,Czyz J.Microalbuminuria:timing is everything![J].Intensive Care Med,2003,29(8):1394-1395.

二级参考文献13

  • 1Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference [ J ] . Crit Care Med, 2003, 31 (4) : 1250- 1256.
  • 2Singri N, Ahya SN, Levin ML Acute renal failure [ J ] . JAMA, 2003, 289 (6): 747-751.
  • 3Vosylius S, Sipylaite J, Ivaskevicius J. Sequential organ failure assessment score as the determinant of outcome for patients with severe sepsis [J] . Croat Med J, 2004, 45 (6) : 715 -720.
  • 4Dellinger RP, Carlet JM, Masur H, et all. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [ J] . Crit Care Meal, 2004, 32 (3): 858-873.
  • 5Shapiro N, Howell MD, Bates DW, et al. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection [ J] . Ann Emerg Med, 2006, 48 (5) : 583 - 590.
  • 6Kleinpell RM, Graves BT, Aekerman MH. Incidence, pathogenesis, and management of sepsis: an overview [ J ] . AACN Adv Crit Care, 2006, 17 (4): 385-393.
  • 7Abraham E, Singer M. Mechanisms of sepsis - induced organ dysfunction [J] . Crit Care Med, 2007, 35 (10): 2408-2416.
  • 8Rivers E, Nguyen B, Havstad S, et al. Early goal - directed therapy in the treatment of severe sepsis and septic shock [J] . N Engl J Med, 2001, 345 (19): 1368-1377.
  • 9Durairaj L, Schmidt GA. Fluid therapy in resuscitated sepsis: less is more [J] .Chest, 2008, 133 (1): 252-263..
  • 10Arts DG, de Keizer NF, Vroom MB, et al. Reliability and accuracy of Sequential Organ Failure Assessment (SOFA) scoring [ J] . Crit Care Med, 2005, 33 (9): 1988-1993.

共引文献10

同被引文献42

  • 1孙丽凤,朴辉日.血清前白蛋白检测及其临床意义[J].中国实验诊断学,2005,9(5):753-753. 被引量:25
  • 2巴立,张茂,干建新,徐少文,江观玉,沈凌伟,傅应裕.血清胆碱酯酶变化与严重多发伤患者病情及转归的关系[J].中华外科杂志,2007,45(13):921-922. 被引量:11
  • 3Endo S,Inada K,Yamada Y,et al.Interleukin 18 (IL-18) levels in patients with sepsis[J].J Med,2000,31(1-2):15-20.
  • 4Charalampos Pierrakos,Jean-louis Vincent.Sepsis biomarkers:a review[J].Critical Care,2010,14:15.
  • 5Phillip Dellinger,Mitchell ML,Jean MC,et al.Surviving sepsis campaign:International guidelines for management of severe sepsis and septic shock:2008[J].Intensive Care Med,2008,34(1):17-60.
  • 6Wiliam PA,Gaby Plamer,Cem Gabay.IL-1,IL-18 and IL-33 families of cytokines[J].Immunological Review,2008,223:20-38.
  • 7Reddy P.Interleukin-18:recent advances[J].Curr Opin Hematol,2004,11(6):405-410.
  • 8Grobmyer SR,Lin E,Lowry SF,et al.Elevation of IL-18 in human sepsis[J].J Clin Immunol,2000,20(3):212-215.
  • 9Knaus WA,Draper EA,Wagner DP,et al.APACHE II:a sererity of disease classification system[J].Crit Care Med,1985,13(10):818-829.
  • 10Salles GF, Cardoso CR, Fiszman R,et al. Prognostic impor tance of baseline and serial changes in microalbuminuria in pa tients with resistant hypertension[J]. Atherosclerosis,2011 216 ( 1), 199-204.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部